Company Profiles

driven by the PitchBook Platform

Mobius Therapeutics

Description

Developer of a drug for glaucoma surgery. The company provides antifibrotic agents such as mitomycin-c to ophthalmic surgeons which can be used during glaucoma, refractive, and corneal surgeries.

2006

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$5M

Latest Deal Amount

$9.3M

Total Amount Raised

Description

Developer of a drug for glaucoma surgery. The company provides antifibrotic agents such as mitomycin-c to ophthalmic surgeons which can be used during glaucoma, refractive, and corneal surgeries.

Website:

www.mobiustherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Surgical Devices

Primary Office

1000 Executive Parkway Suite 224 St. Louis, MO 63141United States +1 (314) 615-6930
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Mobius Therapeutics's full profile, request a free trial.

Mobius Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Mobius Therapeutics Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Accelerate St. LouisAccelerator/IncubatorMinority000 0000000 0000
BioGeneratorNot-For-Profit Venture CapitalMinority000 0000000 0000
Compass Group Equity PartnersPE/BuyoutMinority000 0000000 0000
Cultivation CapitalVenture CapitalMinority000 0000000 0000
National Institute on Deafness and Other Communication DisordersGovernment000 0000000 0000
Accelerate St. Louis Accelerator/Incubator
BioGenerator Not-For-Profit Venture Capital
Compass Group Equity Partners PE/Buyout
Cultivation Capital Venture Capital
National Institute on Deafness and Other Communication Disorders Government

Mobius Therapeutics Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Ed TimmPresident, Chief Executive Officer, Board Member & Founder
Mark WrightChief Financial Officer
Carla TimmDirector of Operations, Customer Service, Sales Support and Marcom
Alan BeckmanDirector of Regulatory Affairs/Quality Assurance
Kate NortonDirector of Supply Chain and Controller
Ed Timm President, Chief Executive Officer, Board Member & Founder
Mark Wright Chief Financial Officer
Carla Timm Director of Operations, Customer Service, Sales Support and Marcom
Alan Beckman Director of Regulatory Affairs/Quality Assurance
Kate Norton Director of Supply Chain and Controller

Mobius Therapeutics Board Members (1)

NameRepresentingRoleSinceContact
Info
Dean VandeKampCultivation CapitalGeneral Partner000 0000
Dean VandeKamp General Partner Cultivation Capital
Request full access to PitchBook